Lyra Therapeutics (LYRA) News Today → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free LYRA Stock Alerts $5.19 -0.20 (-3.71%) (As of 04/19/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePrivate equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as wellfinance.yahoo.com - March 26 at 9:28 PMLyra Therapeutics (NASDAQ:LYRA) Price Target Cut to $11.00marketbeat.com - March 25 at 8:10 AMLyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projectionsfinance.yahoo.com - March 23 at 5:46 AMOptimistic Buy Rating for Lyra Therapeutics’ LYR-210 Amidst Phase 3 Trial and Market Opportunitymarkets.businessinsider.com - March 22 at 7:46 PMLyra Therapeutics files for $300M mixed shelfmsn.com - March 22 at 7:46 PMLyra Therapeutics (NASDAQ:LYRA) Receives "Buy" Rating from HC Wainwrightmarketbeat.com - March 22 at 8:17 AMLyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - March 21 at 4:01 PMLyra Therapeutics, Inc. (NASDAQ:LYRA) Short Interest Down 13.6% in Februarymarketbeat.com - March 16 at 6:46 PMLYRA Jul 2024 2.500 callfinance.yahoo.com - March 15 at 11:36 PMLYRA Jul 2024 7.500 callfinance.yahoo.com - March 15 at 1:27 PMLYRA Apr 2024 7.500 putfinance.yahoo.com - March 15 at 2:57 AMLYRA May 2024 7.500 callfinance.yahoo.com - March 15 at 2:57 AMArmistice Capital LLC Cuts Position in Lyra Therapeutics, Inc. (NASDAQ:LYRA)marketbeat.com - March 3 at 10:50 AMLyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 1 at 4:01 PMHere's What Could Help Lyra Therapeutics, Inc. (LYRA) Maintain Its Recent Price Strengthfinance.yahoo.com - February 21 at 4:36 PMLyra Therapeutics (NASDAQ:LYRA) Trading Down 1%marketbeat.com - February 14 at 2:25 AMLyra Therapeutics invests in Mass. manufacturing with new HQbizjournals.com - February 12 at 7:51 AMThese are the 7 healthcare startups primed to IPO when the market reopensbusinessinsider.com - January 29 at 7:03 AM15 Unhappiest States in the USmsn.com - January 28 at 8:13 PMWhat Makes Lyra Therapeutics, Inc. (LYRA) a Good Fit for 'Trend Investing'finance.yahoo.com - January 17 at 3:59 PMLyra Therapeutics, Inc. (NASDAQ:LYRA) Sees Significant Decline in Short Interestmarketbeat.com - December 30 at 2:21 PMLyra Therapeutics Stock (NASDAQ:LYRA) Dividends: History, Yield and Datesbenzinga.com - December 27 at 9:04 AMAnalysts Issue Forecasts for Lyra Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:LYRA)marketbeat.com - December 21 at 7:46 AMLyra Therapeutics' (LYRA) Overweight Rating Reiterated at Cantor Fitzgeraldmarketbeat.com - December 21 at 7:36 AMPerceptive Advisors LLC Purchases 3,610,832 Shares of Lyra Therapeutics, Inc. (NASDAQ:LYRA)marketbeat.com - December 13 at 10:59 AMExecutive Chairman of Lyra Therapeutics Harlan Waksal Buys 11% More Sharesfinance.yahoo.com - November 15 at 7:30 AMLyra Therapeutics Insider Ups Holding By 11% During Yearfinance.yahoo.com - November 15 at 7:30 AMExecutive Chair of Lyra Therapeutics Purchased $74K In Stockbenzinga.com - November 14 at 4:29 PMSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Lyra Therapeutics, Inc. (NASDAQ: LYRA) and Encourages Investors to Contact the Firmbenzinga.com - November 11 at 9:39 AMLyra Therapeutics GAAP EPS of -$0.27, revenue of $544Mmsn.com - November 7 at 9:03 PMLyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 7 at 9:03 PMLyra Therapeutics Announces Appointment of Ronan O'Brien as Chief Legal Officerbenzinga.com - October 16 at 8:25 AMLyra Therapeutics Announces Appointment of Ronan O’Brien as Chief Legal Officerfinance.yahoo.com - October 16 at 8:25 AMLyra Therapeutics, Inc.'s (NASDAQ:LYRA) market cap dropped US$20m last week; Private equity firms bore the bruntfinance.yahoo.com - October 11 at 7:30 AMLyra Therapeutics: Hold For Phase 3 Toplinemsn.com - October 10 at 4:06 PMLyra Therapeutics' Nasal Matrix In Focus: Sniffing Out Opportunitymsn.com - October 9 at 9:01 AMWhat 4 Analyst Ratings Have To Say About Lyra Therapeuticsmarkets.businessinsider.com - October 6 at 1:37 PMHC Wainwright & Co. Reiterates Lyra Therapeutics (LYRA) Buy Recommendationmsn.com - October 3 at 8:23 AMWilliam Blair Analysts Raise Earnings Estimates for Lyra Therapeutics, Inc. (NASDAQ:LYRA)marketbeat.com - September 15 at 7:33 AMLyra (LYRA) Posts Upbeat Data on Rhinosinusitis Study, Stock Upfinance.yahoo.com - September 13 at 7:15 PMB of A Securities Maintains Lyra Therapeutics (LYRA) Buy Recommendationnasdaq.com - September 12 at 9:01 PMH.C. Wainwright Keeps Their Buy Rating on Lyra Therapeutics (LYRA)markets.businessinsider.com - September 12 at 4:00 PMLyra Therapeutics Phase 2 Chronic Rhinosinusitis Study Hits Main Endpoint >LYRAmarketwatch.com - September 12 at 10:10 AMLyra Therapeutics Shares Rise Premarket on Phase 2 Study Successmarketwatch.com - September 12 at 10:10 AMLyra Therapeutics Reports Positive Topline Results From BEACON Phase 2 Study Of LYR-220markets.businessinsider.com - September 12 at 10:10 AMLyra Therapeutics Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220 for the Treatment of Chronic Rhinosinusitis (CRS) in Patients with Prior Ethmoid Sinus Surgeryfinance.yahoo.com - September 12 at 10:10 AMmarketbeat.com - September 12 at 6:56 AMLyra Therapeutics to Participate in Upcoming Investor Conferencesfinance.yahoo.com - September 6 at 7:12 PMEquities Analysts Set Expectations for Lyra Therapeutics, Inc.'s Q3 2023 Earnings (NASDAQ:LYRA)marketbeat.com - September 4 at 1:27 AMIs Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Deliver On Growth Plans?finance.yahoo.com - August 31 at 8:02 PM Get Lyra Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. LYRA Media Mentions By Week LYRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LYRA News Sentiment▼0.000.52▲Average Medical News Sentiment LYRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LYRA Articles This Week▼01▲LYRA Articles Average Week Get Lyra Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GUTS News Today CERS News Today TCMD News Today CVRX News Today LUNG News Today BVS News Today NPCE News Today SRDX News Today ANIK News Today ANGO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LYRA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.